title: Angiogenic activity of sera from pulmonary tuberculosis patients in relation to IL-12p40 and TNFα serum levels.
abstract: The role of angiogenesis in the pathogenesis of tuberculosis (TB) is not clear. The aim of this study was to examine the effect of sera from TB patients on angiogenesis induced by different subsets of normal human mononuclear cells (MNC) in relation to IL-12p40 and TNFα serum levels. Serum samples from 36 pulmonary TB patients and from 22 healthy volunteers were evaluated. To assess angiogenic reaction the leukocytes-induced angiogenesis test according to Sidky and Auerbach was performed. IL-12p40 and TNFα serum levels were evaluated by ELISA. Sera from TB patients significantly stimulated angiogenic activity of MNC compared to sera from healthy donors and PBS (p < 0.001). The number of microvessels formed after injection of lymphocytes preincubated with sera from TB patients was significantly lower compared to the number of microvessels created after injection of MNC preincubated with the same sera (p < 0.016). However, the number of microvessels created after the injection of lymphocytes preincubated with sera from healthy donors or with PBS alone was significantly higher (p < 0.017). The mean levels of IL-12p40 and TNFα were significantly elevated in sera from TB patients compared to healthy donors. We observed a correlation between angiogenic activity of sera from TB patients and IL-12p40 and TNFα serum levels (p < 0.01). Sera from TB patients constitute a source of mediators that participate in angiogenesis and prime monocytes for production of proangiogenic factors. The main proangiogenic effect of TB patients' sera is mediated by macrophages/monocytes. TNFα and IL-12p40 may indirectly stimulate angiogenesis in TB.
authors: Department of Family Medicine, Medical University of Warsaw, Banacha Street 1a, Warsaw, 02-097, Poland. tmzielonka@wp.pl
authors: Tadeusz M
authors: TM
authors: Zielonka
authors: Urszula
authors: U
authors: Demkow
authors: Dorota
authors: D
authors: Michalowska-Mitczuk
authors: Malgorzata
authors: M
authors: Filewska
authors: Beata
authors: B
authors: Bialas
authors: Katarzyna
authors: K
authors: Zycinska
authors: Michael H
authors: MH
authors: Obrowski
authors: Jan
authors: J
authors: Kus
authors: Ewa
authors: E
authors: Skopinska-Rozewska
references: J Exp Med. 1975 May 1;141(5):1084-1100
references: 236355
references: Chest. 2005 Jul;128(1):468; author reply 468-9
references: 16002978
references: Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1120-2
references: 10988140
references: J Exp Med. 1997 Jul 7;186(1):39-45
references: 9206995
references: Eur Respir J. 2001 May;17(5):1049-51
references: 11488308
references: Respir Res. 2002;3:5
references: 11806840
references: Curr Opin Immunol. 1995 Aug;7(4):485-96
references: 7495512
references: Angiogenesis. 1998;2(4):287-94
references: 14517449
references: Nature. 2000 Sep 14;407(6801):249-57
references: 11001068
references: Cell Struct Funct. 2001 Feb;26(1):25-35
references: 11345501
references: Eur J Clin Invest. 2003 Sep;33(9):758-61
references: 12925034
references: Thorax. 2004 Jul;59(7):581-5
references: 15223865
references: J Neurol Sci. 2001 May 1;186(1-2):75-9
references: 11412875
references: Methods. 1996 Apr;9(2):204-14
references: 8812670
references: Respirology. 2006 Jul;11(4):407-13
references: 16771909
references: J Clin Invest. 1994 Apr;93(4):1733-9
references: 7909320
references: Mol Cell Biol. 1997 Jul;17(7):4015-23
references: 9199336
references: Thorax. 1996 Mar;51(3):306-11
references: 8779137
references: Eur Respir J. 1998 Sep;12(3):716-38
references: 9762805
references: Am J Respir Crit Care Med. 1999 Jan;159(1):143-8
references: 9872832
references: Am Rev Respir Dis. 1989 Nov;140(5):1446-9
references: 2479307
references: J Immunol. 1997 Sep 15;159(6):3034-43
references: 9300729
references: Cancer Res. 2000 Feb 15;60(4):1111-6
references: 10706132
references: Microcirculation. 1997 Jun;4(2):211-32
references: 9219215
references: Tuberculosis (Edinb). 2001;81(5-6):335-41
references: 11800584
references: J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):767-80
references: 18204191
references: J Immunol. 2001 Jun 15;166(12):7469-76
references: 11390500
references: Chest. 2004 Jun;125(6):2156-9
references: 15189936
references: Infect Immun. 1997 Apr;65(4):1364-9
references: 9119475
references: J Pathol. 1983 Oct;141(2):97-112
references: 6363646
references: J Exp Med. 1993 Apr 1;177(4):1199-204
references: 8096238
references: Am J Respir Crit Care Med. 1999 Oct;160(4):1119-23
references: 10508796
references: FASEB J. 1997 May;11(6):457-65
references: 9194526
references: Infect Immun. 2000 Apr;68(4):2043-52
references: 10722600
references: J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):753-66
references: 18204190
references: Infect Immun. 2000 Oct;68(10):5991-7
references: 10992511
references: Pharmacol Rev. 2000 Jun;52(2):237-68
references: 10835101
references: Am J Respir Crit Care Med. 2005 Feb 1;171(3):261-8
references: 15502109
references: J Clin Invest. 1999 Jan;103(1):3-4
references: 9884327
references: Respiration. 2001;68(5):496-500
references: 11694812
references: Lung. 2010 Oct;188(5):375-80
references: 20607270
references: Lung. 2003;181(5):259-65
references: 14705769
references: Respirology. 2004 Mar;9(1):81-6
references: 14982607
references: J Immunol. 2001 Mar 15;166(6):4223-30
references: 11238675
references: Indian J Ophthalmol. 2007 Mar-Apr;55(2):95-102
references: 17322597
references: Nat Med. 1999 Dec;5(12):1390-5
references: 10581081
references: Cancer. 1999 Jan 1;85(1):178-87
references: 9921991